NCT01666184Unknown不适用
Biomarkers Study in Pancreatic Cancer
National Health Research Institutes, Taiwan0 个研究点目标入组 270 人开始时间: 2012年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 270
研究概览
简要总结
Study Design:
Patients are eligible if (1) enrolled to TCOG 3207(2) received surgery or biopsy for pancreatic cancer; (3) willing to sign informed consent.
The pancreatic tumor, tissue specimen and blood sample before or after treatment will be collected from department of pathology, surgery or diagnostic medicine.
详细描述
We expect to collect tissue samples from 270 pancreatic cancer patients of any stages. Since the enrollment criteria are not limited to new patients, we expect to enroll 67 patients a year. The patient enrollment will be completed in 4 years. Clinical follow-up will be completed in another one year. Data analysis and correlation study may be finished in the end of 5th year of this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients enrolled to TCOG 3207 study: A Randomized Phase III Study of Adjuvant Gemcitabine versus Gemcitabine Plus Concurrent Chemoradiation in Pancreatic Cancer Underwent Curative Intent (R0 / R1) Resection.
- •Patients who were not eligible for TCOG 3207 study but received surgery or biopsy for pancreatic cancer.
- •Patients have to sign informed consent for tissue specimen collection, according to the regulation of DOH.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid BiopsyPancreas AdenocarcinomaNCT04241367National Cancer Center, Korea420
已完成
不适用
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving ChemotherapyPancreatic CancerNCT04281511National Cancer Center, Korea238
招募中
不适用
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")Pancreatic CancerNCT03311776Inna Chen, MD5,000
Unknown
3 期
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic CancerPancreatic CancerNCT02355119Azienda Ospedaliero, Universitaria Pisana310
尚未招募
不适用
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the PancreasPAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREASNCT06000553Institut Paoli-Calmettes360